Cargando…
Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
Recurrent fusion genes involving C11orf95, C11orf95‐RELA, have been identified only in supratentorial ependymomas among primary CNS tumors. Here, we report hitherto histopathologically unclassifiable high‐grade tumors, under the tentative label of “ependymoma‐like tumors with mesenchymal differentia...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412126/ https://www.ncbi.nlm.nih.gov/pubmed/33576087 http://dx.doi.org/10.1111/bpa.12943 |
_version_ | 1783747397031034880 |
---|---|
author | Tomomasa, Ran Arai, Yasuhito Kawabata‐Iwakawa, Reika Fukuoka, Kohei Nakano, Yoshiko Hama, Natsuko Nakata, Satoshi Suzuki, Nozomi Ishi, Yukitomo Tanaka, Shinya Takahashi, Jun A. Yuba, Yoshiaki Shiota, Mitsutaka Natsume, Atsushi Kurimoto, Michihiro Shiba, Yoshiki Aoki, Mikiko Nabeshima, Kazuki Enomoto, Toshiyuki Inoue, Tooru Fujimura, Junya Kondo, Akihide Yao, Takashi Okura, Naoki Hirose, Takanori Sasaki, Atsushi Nishiyama, Masahiko Ichimura, Koichi Shibata, Tatsuhiro Hirato, Junko Yokoo, Hideaki Nobusawa, Sumihito |
author_facet | Tomomasa, Ran Arai, Yasuhito Kawabata‐Iwakawa, Reika Fukuoka, Kohei Nakano, Yoshiko Hama, Natsuko Nakata, Satoshi Suzuki, Nozomi Ishi, Yukitomo Tanaka, Shinya Takahashi, Jun A. Yuba, Yoshiaki Shiota, Mitsutaka Natsume, Atsushi Kurimoto, Michihiro Shiba, Yoshiki Aoki, Mikiko Nabeshima, Kazuki Enomoto, Toshiyuki Inoue, Tooru Fujimura, Junya Kondo, Akihide Yao, Takashi Okura, Naoki Hirose, Takanori Sasaki, Atsushi Nishiyama, Masahiko Ichimura, Koichi Shibata, Tatsuhiro Hirato, Junko Yokoo, Hideaki Nobusawa, Sumihito |
author_sort | Tomomasa, Ran |
collection | PubMed |
description | Recurrent fusion genes involving C11orf95, C11orf95‐RELA, have been identified only in supratentorial ependymomas among primary CNS tumors. Here, we report hitherto histopathologically unclassifiable high‐grade tumors, under the tentative label of “ependymoma‐like tumors with mesenchymal differentiation (ELTMDs),” harboring C11orf95‐NCOA1/2 or ‐RELA fusion. We examined the clinicopathological and molecular features in five cases of ELTMDs. Except for one adult case (50 years old), all cases were in children ranging from 1 to 2.5 years old. All patients presented with a mass lesion in the cerebral hemisphere. Histologically, all cases demonstrated a similar histology with a mixture of components. The major components were embryonal‐appearing components forming well‐delineated tumor cell nests composed of small uniform cells with high proliferative activity, and spindle‐cell mesenchymal components with a low‐ to high‐grade sarcoma‐like appearance. The embryonal‐appearing components exhibited minimal ependymal differentiation including a characteristic EMA positivity and tubular structures, but histologically did not fit with ependymoma because they lacked perivascular pseudorosettes, a histological hallmark of ependymoma, formed well‐delineated nests, and had diffuse and strong staining for CAM5.2. Molecular analysis identified C11orf95‐NCOA1, ‐NCOA2, and ‐RELA in two, one, and two cases, respectively. t‐distributed stochastic neighbor embedding analysis of DNA methylation data from two cases with C11orf95‐NCOA1 or ‐NCOA2 and a reference set of 380 CNS tumors revealed that these two cases were clustered together and were distinct from all subgroups of ependymomas. In conclusion, although ELTMDs exhibited morphological and genetic associations with supratentorial ependymoma with C11orf95‐RELA, they cannot be regarded as ependymoma. Further analyses of more cases are needed to clarify their differences and similarities. |
format | Online Article Text |
id | pubmed-8412126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84121262021-09-03 Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma Tomomasa, Ran Arai, Yasuhito Kawabata‐Iwakawa, Reika Fukuoka, Kohei Nakano, Yoshiko Hama, Natsuko Nakata, Satoshi Suzuki, Nozomi Ishi, Yukitomo Tanaka, Shinya Takahashi, Jun A. Yuba, Yoshiaki Shiota, Mitsutaka Natsume, Atsushi Kurimoto, Michihiro Shiba, Yoshiki Aoki, Mikiko Nabeshima, Kazuki Enomoto, Toshiyuki Inoue, Tooru Fujimura, Junya Kondo, Akihide Yao, Takashi Okura, Naoki Hirose, Takanori Sasaki, Atsushi Nishiyama, Masahiko Ichimura, Koichi Shibata, Tatsuhiro Hirato, Junko Yokoo, Hideaki Nobusawa, Sumihito Brain Pathol Research Articles Recurrent fusion genes involving C11orf95, C11orf95‐RELA, have been identified only in supratentorial ependymomas among primary CNS tumors. Here, we report hitherto histopathologically unclassifiable high‐grade tumors, under the tentative label of “ependymoma‐like tumors with mesenchymal differentiation (ELTMDs),” harboring C11orf95‐NCOA1/2 or ‐RELA fusion. We examined the clinicopathological and molecular features in five cases of ELTMDs. Except for one adult case (50 years old), all cases were in children ranging from 1 to 2.5 years old. All patients presented with a mass lesion in the cerebral hemisphere. Histologically, all cases demonstrated a similar histology with a mixture of components. The major components were embryonal‐appearing components forming well‐delineated tumor cell nests composed of small uniform cells with high proliferative activity, and spindle‐cell mesenchymal components with a low‐ to high‐grade sarcoma‐like appearance. The embryonal‐appearing components exhibited minimal ependymal differentiation including a characteristic EMA positivity and tubular structures, but histologically did not fit with ependymoma because they lacked perivascular pseudorosettes, a histological hallmark of ependymoma, formed well‐delineated nests, and had diffuse and strong staining for CAM5.2. Molecular analysis identified C11orf95‐NCOA1, ‐NCOA2, and ‐RELA in two, one, and two cases, respectively. t‐distributed stochastic neighbor embedding analysis of DNA methylation data from two cases with C11orf95‐NCOA1 or ‐NCOA2 and a reference set of 380 CNS tumors revealed that these two cases were clustered together and were distinct from all subgroups of ependymomas. In conclusion, although ELTMDs exhibited morphological and genetic associations with supratentorial ependymoma with C11orf95‐RELA, they cannot be regarded as ependymoma. Further analyses of more cases are needed to clarify their differences and similarities. John Wiley and Sons Inc. 2021-02-12 /pmc/articles/PMC8412126/ /pubmed/33576087 http://dx.doi.org/10.1111/bpa.12943 Text en © 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Tomomasa, Ran Arai, Yasuhito Kawabata‐Iwakawa, Reika Fukuoka, Kohei Nakano, Yoshiko Hama, Natsuko Nakata, Satoshi Suzuki, Nozomi Ishi, Yukitomo Tanaka, Shinya Takahashi, Jun A. Yuba, Yoshiaki Shiota, Mitsutaka Natsume, Atsushi Kurimoto, Michihiro Shiba, Yoshiki Aoki, Mikiko Nabeshima, Kazuki Enomoto, Toshiyuki Inoue, Tooru Fujimura, Junya Kondo, Akihide Yao, Takashi Okura, Naoki Hirose, Takanori Sasaki, Atsushi Nishiyama, Masahiko Ichimura, Koichi Shibata, Tatsuhiro Hirato, Junko Yokoo, Hideaki Nobusawa, Sumihito Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma |
title | Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma |
title_full | Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma |
title_fullStr | Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma |
title_full_unstemmed | Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma |
title_short | Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma |
title_sort | ependymoma‐like tumor with mesenchymal differentiation harboring c11orf95‐ncoa1/2 or ‐rela fusion: a hitherto unclassified tumor related to ependymoma |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412126/ https://www.ncbi.nlm.nih.gov/pubmed/33576087 http://dx.doi.org/10.1111/bpa.12943 |
work_keys_str_mv | AT tomomasaran ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT araiyasuhito ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT kawabataiwakawareika ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT fukuokakohei ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT nakanoyoshiko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT hamanatsuko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT nakatasatoshi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT suzukinozomi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT ishiyukitomo ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT tanakashinya ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT takahashijuna ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT yubayoshiaki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT shiotamitsutaka ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT natsumeatsushi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT kurimotomichihiro ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT shibayoshiki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT aokimikiko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT nabeshimakazuki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT enomototoshiyuki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT inouetooru ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT fujimurajunya ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT kondoakihide ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT yaotakashi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT okuranaoki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT hirosetakanori ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT sasakiatsushi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT nishiyamamasahiko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT ichimurakoichi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT shibatatatsuhiro ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT hiratojunko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT yokoohideaki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma AT nobusawasumihito ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma |